PDB45 THE BUDGET IMPACT OF SITAGLIPTIN VERSUS ORAL SEMAGLUTIDE FROM A US PAYER PERSPECTIVE
May 1, 2020, 00:00 AM
10.1016/j.jval.2020.04.232
https://www.valueinhealthjournal.com/article/S1098-3015(20)30420-4/fulltext
Section Title :
Section Order :
10087
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30420-4&doi=10.1016/j.jval.2020.04.232